closantel has been researched along with Day Blindness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alizadeh, Y; Azaripour, E; Behboudi, H; Medghalchi, A; Moravvej, Z; Soltani-Moghadam, R | 1 |
| Abrishami, M; Inanlou, B; Mansouri, MR; Masarat, H; Mirshahi, A; Pakrah, AR; Soleimani, M; Tabatabaei, SA | 1 |
2 other study(ies) available for closantel and Day Blindness
| Article | Year |
|---|---|
Closantel retinal toxicity: Recovery from severe vision loss after corticosteroid therapy.
Topics: Adrenal Cortex Hormones; Adult; Female; Humans; Retina; Salicylanilides; Tomography, Optical Coherence; Vision Disorders | 2023 |
Closantel; a veterinary drug with potential severe morbidity in humans.
Topics: Adult; Anthelmintics; Humans; Male; Retinal Diseases; Salicylanilides; Veterinary Drugs; Vision Disorders | 2016 |